US Patent 11833223 Antibodies, pharmaceutical compositions and methods
Patent 11833223 was granted and assigned to OBI Pharma, Inc. on December, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11833223 Antibodies, pharmaceutical compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
